May 21 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS SUPPORTS TRIAL TO INVESTIGATE THE EFFECTS OF VASCEPA® (ICOSAPENT ETHYL) AGAINST COVID-19
* HLS THERAPEUTICS INC - IN COLLABORATION WITH AMARIN, IT IS SUPPORTING A TRIAL TO INVESTIGATE EFFECTS OF VASCEPA